Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift. - Speirs MMP; Swensen AC; Chan TY; Jones PM; Holman JC; Harris MB; Maschek JA; Cox JE; Carson RH; Hill JT; Andersen JL; Prince JT; et al. (Oncotarget, 2019)